Challenges of HPV vaccination in Covid-۱۹ epidemics

The HPV vaccine can reduce the risk of cervical cancer and improve the quality of life. HPV vaccination has been severely reduced by the COVID-۱۹ epidemic. The present study aimed to review the effect of epidemics on reducing HPV vaccine intake. Barriers to vaccination were assessed in three groups: individual, structural, logistical, and social. Individual barriers included fear of Covid-۱۹ exposure, lack of awareness, and anxiety. Structural and logistical barriers included the unavailability of services due to COVID-۱۹, interruption of school vaccinations, lack of personal protective equipment, and delays in diagnosis and treatment. Social and economic barriers included transportation delays, travel restrictions, social distance, anti-vaccine campaigns, high vaccine costs, global vaccine supply shortages, recession, and extreme poverty. Conclusion: Considering that HPV vaccination is a strategy to prevent cervical cancer, and since Covid-۱۹ has made it difficult to access the HPV vaccine, adopt health strategies and policies, including public education and information, vaccination Based on the school, it is essential to provide a single dose of the HPV vaccine until the problems with access to and delivery of the vaccine are resolved.

Keywords:

HPV Vaccine , COVID-۱۹ Epidemic , Cervical Cancer